Action Pharma A/S
π©π°Denmark
- Country
- π©π°Denmark
- Ownership
- Private, Subsidiary
- Established
- 2000-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.actionpharma.com
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
Phase 2
Completed
- Conditions
- Cardiac SurgeryCoronary Artery BypassAortic AneurysmValve SurgeryKidney Diseases
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Action Pharma A/S
- Target Recruit Count
- 77
- Registration Number
- NCT01256372
- Locations
- π©π°
University Hospital Copenhagen, Rigshospitalet, Copenhagen, Denmark
Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery
Phase 2
Completed
- Conditions
- Cardiac SurgeryCoronary Artery Bypass GraftingValve SurgeryAortic Root or Ascending Aortic Aneurysm Repair Surgery
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-05-18
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Action Pharma A/S
- Target Recruit Count
- 42
- Registration Number
- NCT00903604
- Locations
- π©π°
Odense University Hospital, Department of Cardiac, Thoracic and Vascular Surgery, Odense, Denmark
π©π°Department of Cardiac and Thoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery
Phase 2
Terminated
- Conditions
- Coronary Artery Bypass GraftingValve SurgeryKidney InjuryCardiac Surgery
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2009-06-01
- Lead Sponsor
- Action Pharma A/S
- Target Recruit Count
- 75
- Registration Number
- NCT00628264
- Locations
- πΊπΈ
Shands Hopsital at University of Florida, Gainesville, Florida, United States
πΊπΈShands Hospital at Alachua General Hospital, Gainesville, Florida, United States
Β© Copyright 2025. All Rights Reserved by MedPath